Verax Biomedical Receives $4,000,000 New Funding Round

  • Feed Type
  • Date
    1/22/2015
  • Company Name
    Verax Biomedical
  • Mailing Address
    148 Bartlett Street Marlborough, MA 01752 USA
  • Company Description
    Verax Biomedical is a leader in the development of rapid tests designed to detect a broad range of bacterial contaminants based upon its proprietary Pan Genera Detection (PGD) technology.
  • Website
    http://www.veraxbiomedical.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy